Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of NED

24th Mar 2015 07:01

RNS Number : 2430I
Low & Bonar PLC
24 March 2015
 



Low & Bonar PLC

 

Appointment of Non-executive Director

 

Low & Bonar PLC ("Low & Bonar" or the "Group"), the international performance materials group, is pleased to announce the appointment of Kevin Matthews as a non-executive director with effect from 1 April 2015.

 

Kevin Matthews is Chief Executive Officer of Revolymer plc, an AIM listed company that designs, develops and formulates novel polymers to improve the performance of consumer products within the FMCG and other industrial markets. From 2009 to 2014, he was Chief Executive Officer of Isogenica Limited, a UK based private biotechnology business. Kevin was also a non-executive director of Elementis PLC (a FTSE 250 specialty chemicals company) from 2005 to 2014 including being chairman of its Remuneration Committee.

 

There is no further information required to be disclosed in relation to Mr Matthews pursuant to Listing Rule 9.6.13 R.

 

Martin Flower, Chairman of Low & Bonar, comments:

 

"We are delighted to welcome Kevin to the Group. His extensive experience in technology and specialty chemicals businesses will be of great value to the Board as the Group pursues its strategy of profitable growth through internationalisation and innovation."

 

For further information, please contact:

 

Low & Bonar PLC

020 7535 3180

Brett Simpson, Group Chief Executive

Mike Holt, Group Finance Director

Instinctif

020 7457 2020

Matthew Smallwood

Helen Tarbet

 

 

 

Notes to Editors

Kevin Matthews's former appointments have included: CEO of Isogenica Limited; non-executive director of Elementis PLC; CEO of Oxonica plc, a UK based nanotechnology company, from 2001 to 2009; roles in Rhodia Consumer Specialties Limited, Albright & Wilson UK Limited and ICI Chemicals and Polymers: non-executive director of Cellectricon AB, a Swedish private biotechnology business (2011-2014); he holds a D.Phil in chemistry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEWFADFISEFD

Related Shares:

LWB.L
FTSE 100 Latest
Value8,275.66
Change0.00